REDHILL BIOPHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4628 USD | +1.71% |
|
-2.28% | -68.30% |
| 06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
| 06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 14.75M | - | - | - | - | - | |
| 90.02B | ||||||
| 39.15B | ||||||
| 31.71B | ||||||
| 26.47B | ||||||
| 14.34B |
